Precision Medicine : Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy |
Autore | Turgeon Jacques |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (170 p.) |
Soggetto topico |
Medicine
Clinical & internal medicine |
Soggetto non controllato |
fibromyalgia (FM)
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) microRNA miRNome pharmacogenomics pharmacoepigenomics SM2miR Pharmaco-miR repoDB ME/CFS Common Data Elements (CDEs) dihydropyrimidine dehydrogenase DPYD 5-fluorouracil fluoropyrimidine therapeutic drug monitoring orthotopic liver transplant busulfan glutathione S-transferase genetic polymorphism limited sampling strategy pharmacokinetics clinical pharmacogenetics pharmacogenetic testing adverse drug reactions genotype phenotype pharmacogene barriers to pharmacogenetics implementation Sub-Saharan Africa chronic low back pain (cLBP) genetics personalized treatment polymorphism CYP450 tacrolimus CYP3A5 liver transplant pharmacogenomic minority data collection drug biomarker pharmacogenetics pharmacogenetic test personalized medicine gene expression infliximab adalimumab ulcerative colitis Crohn disease inflammatory bowel disease |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Precision Medicine |
Record Nr. | UNINA-9910585940803321 |
Turgeon Jacques
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Research of Pathogenesis and Novel Therapeutics in Arthritis / Chih-Hsin Tang |
Autore | Tang Chih-Hsin |
Pubbl/distr/stampa | Basel, Switzerland : , : MDPI, , 2019 |
Descrizione fisica | 1 electronic resource (366 p.) |
Soggetto non controllato |
receptor activator of nuclear factor ?B
infliximab tripterine triptolide osteoblast tumor necrosis factor-alpha synovial cell anti-arthritis biosimilars Epstein-Barr virus cytokines SOX9 parathyroid hormone nitric oxide rat etanercept angiogenesis glycosylation mitogen activated protein kinase Th9 lymphocytes rheumatoid arthritis IL-6 clodronate bone erosion mesenchymal stem cells collagen-induced arthritis biological gene expression inflammatory arthritis osteoarthritis fraxinellone nuclear factor kappa B messenger RNA inflammation miRNA disease-modifying adipokines WNT glycoprotein 42 miR-199a-5p proliferation next-generation sequencing collagen osteoarthritis (OA) experimental arthritis bone morphogenetic protein TNF-? computational modeling basic research osteoclast therapeutics certolizumab pegol chondrocytes progenitor cells adjuvant arthritis adalimumab triterpenoid sclareol TNF? fibroblast growth factor 2 antibodies osteoblasts molecular pathology Th17 immunology obesity visfatin articular cartilage autoimmune biomarkers celastrol MAPK disease pathways IL1? arthritis bioinformatics anticitrullinated peptide antibodies drug delivery system antagonists shared epitope pathology SMA- and MAD-related protein small-molecule inhibitor transforming growth factor ? mice golimumab spinal fusion antirheumatic drug early osteoarthritis stem cell rheumatoid factor therapeutic antibody bisphosphonate osteoclastogenesis interleukin spondyloarthropathies clinical translation therapy Traditional Chinese medicine chemokines structure cell signaling microRNA |
ISBN |
9783038970668
3038970662 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910346843303321 |
Tang Chih-Hsin
![]() |
||
Basel, Switzerland : , : MDPI, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges |
Autore | Müller Rüdiger |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (260 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
rheumatoid arthritis
sleep sleep disorders pain osteoporosis fracture fracture risk assessment tool treat-to-target certolizumab pegol csDMARDs glucocorticoids intra-articular injections DAS 28 ACR response HAQ-DI TNFα golimumab efficacy tolerability immunogenicity methotrexate posology titration oral route subcutaneous route bioavailability effectiveness periodontitis periodontal disease anti-citrullinated protein autoantibodies rheumatoid factor smoking medication Porphyromonas gingivalis Rheumatoid arthritis matrix metalloproteinase 3 infliximab pharmacogenomics anti-TNF personalized medicine baricitinib disease-modifying antirheumatic drugs pain perception outcomes research patient perspective Rheumatoid Arthritis therapy DMARD MTX Tumor Necrosis Factor-Alpha Inhibitors ankylosing spondylitis biosimilar switching synovial fibroblasts cytokine osteoclast herbal medicine methylation next-generation sequencing recovery of function fatigue productivity tofacitinib oral Th1.17 IL-17A IFN-γ, CD73 adenosine psoriatic arthritis regulation pseudoerosions hand foot ultrasonography radiography computed tomography magnetic resonance imaging |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Rheumatoid Arthritis Therapy Reappraisal |
Record Nr. | UNINA-9910557286503321 |
Müller Rüdiger
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|